KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Prepaid Assets (2016 - 2025)

Nektar Therapeutics (NKTR) has 16 years of Prepaid Assets data on record, last reported at $11.1 million in Q3 2025.

  • For Q3 2025, Prepaid Assets rose 24.81% year-over-year to $11.1 million; the TTM value through Sep 2025 reached $11.1 million, up 24.81%, while the annual FY2024 figure was $6.1 million, 37.97% down from the prior year.
  • Prepaid Assets reached $11.1 million in Q3 2025 per NKTR's latest filing, up from $10.7 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $23.3 million in Q4 2021 and bottomed at $6.1 million in Q4 2024.
  • Average Prepaid Assets over 5 years is $13.8 million, with a median of $11.2 million recorded in 2025.
  • Peak YoY movement for Prepaid Assets: crashed 66.65% in 2021, then soared 52.79% in 2022.
  • A 5-year view of Prepaid Assets shows it stood at $23.3 million in 2021, then crashed by 32.25% to $15.8 million in 2022, then tumbled by 38.14% to $9.8 million in 2023, then crashed by 37.97% to $6.1 million in 2024, then skyrocketed by 83.79% to $11.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $11.1 million in Q3 2025, $10.7 million in Q2 2025, and $11.3 million in Q1 2025.